CBD and THC for chronic insomnia

Plain Language Summary

Key Points & Implications

Author(s) & Affiliation(s)

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Full Citation

Suraev, Anastasia, et al. “Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): Protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial.” BMJ Open, vol. 10, no. 5, May 2020, https://doi.org/10.1136/bmjopen-2019-034421.

Full Paper Title:

Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial):
protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial

DOI:

Published:

10.1136/bmjopen-2019-034421

18. Mai 2020

In:

BMJ Open

Inline Citation

(Suraev et al. 2020)